Xi'an Manareco(SH:688550)2025-10-23 11:30Revenue Growth - For the first three quarters of 2025, Xi'an Ruilian New Materials Co., Ltd. expects to achieve operating revenue of CNY 1,301.34 million, an increase of CNY 207.91 million, representing a year-on-year growth of 19.01%[3]. - The pharmaceutical and electronic materials sectors have shown significant revenue growth, enhancing the overall revenue scale and net profit level of the company[8]. Net Profit Projections - The net profit attributable to the parent company for the same period is projected to be CNY 280.81 million, an increase of CNY 95.51 million, reflecting a year-on-year growth of 51.54%[3]. - Excluding the impact of share-based payment expenses, the net profit attributable to the parent company is expected to reach CNY 307.41 million, an increase of CNY 111.51 million, with a year-on-year growth of 56.92%[3]. - The net profit attributable to the parent company after deducting non-recurring gains and losses is anticipated to be CNY 276.95 million, an increase of CNY 103.05 million, indicating a year-on-year growth of 59.26%[3]. - If excluding share-based payment expenses, the net profit after deducting non-recurring gains and losses is expected to be CNY 303.55 million, an increase of CNY 119.05 million, with a year-on-year growth of 64.53%[4]. - The company reported a total profit of CNY 212.58 million and a net profit attributable to the parent company of CNY 185.30 million for the first three quarters of 2024[7]. Performance Forecast Accuracy - The company has not identified any major uncertainties that could affect the accuracy of this performance forecast[9]. - The financial data in this performance forecast has not been audited by an accounting firm and is based on preliminary calculations by the company's finance department[9]. - The official financial data will be disclosed in the company's formal report for the third quarter of 2025[9].